GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Shiller PE Ratio
中文

Hanall Biopharma Co (XKRX:009420) Shiller PE Ratio : 414.27 (As of Apr. 25, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co Shiller PE Ratio?

As of today (2024-04-25), Hanall Biopharma Co's current share price is ₩35300.00. Hanall Biopharma Co's E10 for the quarter that ended in Dec. 2023 was ₩85.21. Hanall Biopharma Co's Shiller PE Ratio for today is 414.27.

The historical rank and industry rank for Hanall Biopharma Co's Shiller PE Ratio or its related term are showing as below:

XKRX:009420' s Shiller PE Ratio Range Over the Past 10 Years
Min: 352.66   Med: 1238.34   Max: 5114.5
Current: 376.72

During the past years, Hanall Biopharma Co's highest Shiller PE Ratio was 5114.50. The lowest was 352.66. And the median was 1238.34.

XKRX:009420's Shiller PE Ratio is ranked worse than
98.25% of 514 companies
in the Drug Manufacturers industry
Industry Median: 24.47 vs XKRX:009420: 376.72

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hanall Biopharma Co's adjusted earnings per share data for the three months ended in Dec. 2023 was ₩-57.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₩85.21 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hanall Biopharma Co Shiller PE Ratio Historical Data

The historical data trend for Hanall Biopharma Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Shiller PE Ratio Chart

Hanall Biopharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 5,350.66 1,287.31 519.90

Hanall Biopharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,287.31 1,059.62 568.81 614.01 519.90

Competitive Comparison of Hanall Biopharma Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hanall Biopharma Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanall Biopharma Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanall Biopharma Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hanall Biopharma Co's Shiller PE Ratio falls into.



Hanall Biopharma Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hanall Biopharma Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=35300.00/85.21
=414.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hanall Biopharma Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Hanall Biopharma Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-57/118.8477*118.8477
=-57.000

Current CPI (Dec. 2023) = 118.8477.

Hanall Biopharma Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 13.000 99.253 15.566
201406 6.000 99.353 7.177
201409 6.000 99.608 7.159
201412 -339.000 99.098 -406.561
201503 8.000 99.720 9.535
201506 -1.000 100.050 -1.188
201509 -57.000 100.110 -67.669
201512 -103.000 100.220 -122.144
201603 33.000 100.560 39.001
201606 25.000 100.790 29.479
201609 -6.000 101.460 -7.028
201612 16.000 101.560 18.724
201703 -8.000 102.850 -9.244
201706 10.000 102.610 11.582
201709 53.000 103.490 60.865
201712 60.000 102.990 69.238
201803 14.000 104.100 15.983
201806 53.000 104.130 60.491
201809 50.000 105.650 56.246
201812 -53.000 104.350 -60.363
201903 64.000 104.490 72.794
201906 82.000 104.880 92.921
201909 107.000 105.200 120.881
201912 122.000 105.120 137.932
202003 76.000 105.540 85.583
202006 115.000 104.870 130.328
202009 73.000 106.200 81.694
202012 122.000 105.765 137.090
202103 88.000 107.357 97.419
202106 64.000 107.579 70.704
202109 40.000 108.759 43.710
202112 -18.000 109.676 -19.505
202203 -2.000 111.806 -2.126
202206 -2.000 114.083 -2.084
202209 14.000 114.831 14.490
202212 -6.000 115.200 -6.190
202303 -25.000 116.550 -25.493
202306 144.000 117.140 146.099
202309 6.000 119.111 5.987
202312 -57.000 118.848 -57.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hanall Biopharma Co  (XKRX:009420) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hanall Biopharma Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanall Biopharma Co (XKRX:009420) Business Description

Traded in Other Exchanges
N/A
Address
12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR
Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co (XKRX:009420) Headlines

No Headlines